Trials / Completed
CompletedNCT01845558
Effects of Wobenzym® Plus in Healthy, Sportive People After Eccentric Exercise
Effects of Wobenzym® Plus in Healthy, Sportive People After Eccentric Exercise - a Randomized, Two-stage, Double-blind, Placebo-controlled Cross-over Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 69 (actual)
- Sponsor
- Mucos Pharma GmbH & Co. KG · Industry
- Sex
- Male
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The aim of the current study is to investigate the therapeutic effect and especially the mode of action of Wobenzym® plus, an anti-inflammatory drug containing proteolytic enzymes, on exercise induced muscle damage (eiMD) and recovery time in male amateur sportsmen with medium proficiency level compared to placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Wobenzym® plus | |
| OTHER | Placebo |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2014-09-01
- Completion
- 2014-09-01
- First posted
- 2013-05-03
- Last updated
- 2015-08-28
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01845558. Inclusion in this directory is not an endorsement.